![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Previsioni di mercato delle particelle simili a virus in Medio Oriente e Africa fino al 2028: impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (Vaccini e terapie)
Introduzione al mercato
Gli Emirati Arabi Uniti (EAU), l\'Arabia Saudita e il Sud Africa sono i principali paesi del Medio Oriente e del Medio Oriente Regione africana. L\'Arabia Saudita è stato il più grande mercato per particelle simili a virus in questa regione nel 2021. Il mercato per particelle simili a virus in Medio Oriente e Medio Oriente; Si prevede che Africa, Arabia Saudita crescerà a un CAGR più elevato durante il periodo di previsione; questa crescita è attribuita alla crescente prevalenza di varie malattie e alle crescenti iniziative governative in termini di finanziamenti e politiche sanitarie.
Le incertezze economiche e i conflitti in corso stanno peggiorando la condizione nella regione . Ad esempio, paesi come Siria, Libia e Yemen stanno soffrendo violenti conflitti e non possono attuare alcuna misura di sanità pubblica. L’Iran era in una profonda recessione economica a causa delle sanzioni statunitensi. Inoltre, anche le rigide condizioni finanziarie stanno diminuendo le attività economiche nella regione. Molti paesi si trovano ad affrontare una carenza di vaccini COVID19 nella regione. Vari paesi sviluppati in via di sviluppo nelle regioni sono in ritardo per le forniture di vaccini COVID19. Pertanto, c’è la possibilità che i produttori globali di vaccini esplorino la sezione non sfruttata dell’Africa mediorientale. Ad esempio, secondo i dati pubblicati dalla Brookings Institution nell’agosto 2021, la vaccinazione nei paesi a basso e medio reddito dell’Africa mediorientale è stata stimata al 25% in Giordania e al 27% in Marocco, mentre nessun paese dell’Africa mediorientale è stato stimato. in grado di fornire a più del 15% della popolazione una dose di vaccino. Pertanto, offre un mercato potenziale per il mercato correlato alla VLP nella regione e ha un impatto positivo sul mercato VLP nella regione.
Panoramica e dinamiche del mercato
Il mercato delle particelle simili ai virus in Medio Oriente e in Medio Oriente Si prevede che l’Africa crescerà da 152,83 milioni di dollari nel 2021 a 249,12 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,2% dal 2021 al 2028. Vari attori del mercato sanitario e organizzazioni di ricerca sono attivamente coinvolti nelle innovazioni e nello sviluppo dei prodotti. L’uso di particelle simili a virus è un approccio emergente utilizzato nell’industria biofarmaceutica. Poiché le particelle simili a virus sono prive del contenuto virale, sono più facili da gestire rispetto ai componenti virali effettivi. I VLP possono essere utilizzati per facilitare la somministrazione di farmaci, l\'imaging, l\'immunoterapia e la terapia terapeutica. Ad esempio, secondo uno studio pubblicato dall\'NCBI nel giugno 2020, la VLP può essere utilizzata sotto forma di nanoparticelle in applicazioni quali terapia fototermica, imaging PET e TC, vettori di agenti di contrasto per MRI, imaging ottico, vaccini per malattie infiammatorie e autoimmuni, immunoterapia antitumorale e somministrazione di farmaci a piccole molecole (nella terapia antitumorale). Pertanto, si prevede che tali potenziali applicazioni dei VLP forniranno opportunità di crescita agli operatori del mercato durante il periodo di previsione.
Segmenti chiave del mercato
In termini di tipologia di prodotto, il segmento dell\'epatite rappresentava la quota maggiore del Medio Oriente e dell\'Europa. Mercato africano delle particelle simili a virus nel 2021. In termini di fonte, il segmento del lievito rappresentava la quota maggiore del Medio Oriente e del Medio Oriente. Mercato africano delle particelle simili a virus nel 2021. In termini di applicazione, il segmento dei vaccini ha detenuto una quota di mercato maggiore del mercato delle particelle simili a virus nel 2021.
Principali fonti e società elencate
Alcune delle principali fonti primarie e secondarie citate per la preparazione di questo rapporto sul mercato delle particelle simili a virus nel Medio Est e; Africa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti del governo nazionale e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Istituto del siero dell\'India Pvt. Ltd.; BIOTECNOLOGIA BHARAT; LG Chem; e VBI Vaccines Inc. tra gli altri.
Motivi per acquistare il rapporto
- Capire il Medio Oriente e il Medio Oriente Panorama del mercato delle particelle simili a virus in Africa e identificazione dei segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
- Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il Medio Oriente & Mercato africano delle particelle simili a virus
- Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership in Medio Oriente e in Medio Oriente. Mercato africano delle particelle simili a virus identificando i segmenti di mercato con le vendite probabili più promettenti
- Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi perspicace e completa delle prestazioni di mercato di vari segmenti dal Medio Oriente & Mercato africano delle particelle simili a virus
- Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 in Medio Oriente e in Asia. Regione africana.
Medio Oriente e Stati Uniti. Segmentazione del mercato delle particelle simili a virus in Africa
< span>Medio Oriente e amp; Mercato delle particelle simili a virus in Africa - Per tipo di prodotto
- Epatite
- Cancro/HPV
- Malattia di Gaucher
Medio Oriente e Stati Uniti. Mercato delle particelle simili a virus in Africa: per fonte
- Lievito
- Insetti Cella
- Pianta
- Altri
< strong>Medio Oriente e amp; Mercato delle particelle simili a virus in Africa - Per applicazione
- Vaccini
- Terapeutica
Medio Oriente e amp; Mercato delle particelle simili a virus in Africa - Per Paese
- Arabia Saudita
- Sudafrica
- Emirati Arabi Uniti
- Resto del MEA ;
Medio Oriente e Stati Uniti. Mercato africano delle particelle simili a virus - Aziende citate
- Merck & Co., Inc. ; \' bsp ;
- GlaxoSmithKline plc.
- Pfizer Inc.  ; \' bsp ; \' bsp ;
- Sanofi ; ;
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH   ; \' bsp ;
- LG Chem ;
- VBI Vaccines Inc. ;
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Virus-like Particles Market – By Product Type
1.3.2 Middle East & Africa Virus-like Particles Market – By Source
1.3.3 Middle East & Africa Virus-like Particles Market – By Application
1.3.4 Middle East & Africa Virus-like Particles Market – By Country
2. Middle East & Africa Virus-like Particles Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Virus-like Particles Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Higher Prevalence of Infectious Viral Diseases
5.1.2 Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Existence of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Increasing Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Regular Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Middle East & Africa Virus-like Particles Market Analysis
6.1 Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis
7. Middle East & Africa Virus-like Particles Market Analysis – by Product Type
7.1 Overview
7.2 Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Virus-like Particles Market Analysis – By Source
8.1 Overview
8.2 Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Virus-like Particles Market Analysis – By Application
9.1 Overview
9.2 Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Virus-like Particles Market – Country Analysis
10.1 Overview
10.1.1 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market
11.1 Impact Assessment of COVID-19 Pandemic
12. Middle East & Africa Virus-like Particles Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Serum Institute of India Pvt. Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BHARAT BIOTECH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LG Chem
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 VBI Vaccines Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 9. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms: Virus-like Particles Market
LIST OF FIGURES
Figure 1. Middle East & Africa Virus-like particles Market Segmentation
Figure 2. Middle East & Africa Virus-like particles Market Segmentation, By Country
Figure 3. Middle East & Africa Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market
Figure 5. Saudi Arabia to Show Significant Growth during Forecast Period
Figure 6. Middle East & Africa Virus-like Particles Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10. Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 23. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 24. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Impact Of COVID-19 Pandemic in Middle East & African Countries
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution